Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics.

Source:http://linkedlifedata.com/resource/pubmed/id/11931615

J. Med. Chem. 2002 Apr 11 45 8 1607-23

Download in:

View as

General Info

PMID
11931615